AVROBIO, Inc., a leader in lentiviral-based gene therapies,
is a clinical stage company developing disruptive therapies that have the potential to transform patients’ lives in a single dose. The aim of AVROBIO’s gene therapy programs is to deliver lasting and meaningful benefits for patients with genetic diseases by restoring normal gene function and enzyme/protein production.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.